Stock Analysis on Net
Stock Analysis on Net

Eli Lilly & Co. (NYSE:LLY)

Common-Size Income Statement 

Eli Lilly & Co., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Revenue 100.00 100.00 100.00 100.00 100.00
Cost of sales -20.75 -23.23 -25.82 -22.34 -21.15
Gross margin 79.25% 76.77% 74.18% 77.66% 78.85%
Research and development -27.29 -25.19 -24.47 -24.35 -25.07
Marketing, selling, and administrative -21.69 -22.57 -22.71 -24.94 -27.84
Acquired in-process research and development -11.14 -3.18 -3.43 -3.14 -1.07
Asset impairment, restructuring, and other special charges -0.20 -0.86 -1.12 -0.53 -2.58
Operating income 18.92% 24.97% 22.45% 24.69% 22.29%
Interest expense -1.42 -1.16 -1.20 -1.47 -1.79
Interest income 0.51 0.22 0.09 0.13 0.36
Net investment gains (losses) on equity securities -0.06 -1.44 0.62 5.88 1.80
Debt extinguishment loss 0.00 0.00 -1.43 0.00 -1.13
Gain on sale of antibiotic business in China 0.00 0.00 0.00 0.00 1.39
Retirement benefit plans 1.35 1.31 1.02 1.03 0.94
Other income (expense) -0.10 -0.05 0.18 -0.80 -0.25
Other, net, income (expense) 0.28% -1.12% -0.71% 4.78% 1.31%
Income before income taxes 19.21% 23.85% 21.74% 29.46% 23.59%
Income taxes -3.85 -1.97 -2.03 -4.22 -2.81
Net income from continuing operations 15.36% 21.88% 19.71% 25.24% 20.78%
Net income from discontinued operations 0.00 0.00 0.00 0.00 16.49
Net income 15.36% 21.88% 19.71% 25.24% 37.27%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Operating income The net result for the period of deducting operating expenses from operating revenues. Eli Lilly & Co. operating income as a percentage of revenue increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Eli Lilly & Co. income before income taxes as a percentage of revenue increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Eli Lilly & Co. net income as a percentage of revenue increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.